Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 94
Filter
1.
Leuk Res ; 52: 28-33, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27870946

ABSTRACT

BACKGROUND: High hyperdiploid (HeH) pre-B pediatric acute lymphoblastic leukemia (B-pALL) is known to be heterogeneous by prognosis, but the stratification principals according to conventional cytogenetic analysis (CCA) are equivocal. PROCEDURE: Untreated bone marrow samples of 214 B-pALL patients were previously classified according to the modal numbers (iMN8) based on the gains of the chromosomes 4, 6, 10, 14, 17, 18, 21, and X as revealed by consecutive and correlated 2×4 color interphase fluorescence in situ hybridization, and at least five years of follow up data were analyzed. RESULTS: Data from 48 of the 53 HeH (iMN8>50) B-pALL patients indicated that among the age, gender, WBC, and iMN8 parameters, only the last was significantly associated with overall survival (pOS), which allowed the cases to be classified as iMN8 51-54 (75%) and iMN8 ≥ 55 (95%). Among the specific chromosomal gains of +4, +4/+6, +4/+17 and +4/+18, the first exhibited the most significance in terms of beneficial outcomes. The better prognostic group according to the iMN8 was associated with a significantly reduced complexity of the subclonal landscape. However, iMN8 did not prove to be an independent variable but was instead overridden by isolated trisomy of chromosome 4. CONCLUSIONS: These data indicate that the better outcomes in the HeH B-pALL group arose from the gain of a specific chromosome that always ranks at the same position in the sequential acquisition of the affected chromosomes.


Subject(s)
Chromosomes, Human, Pair 4/genetics , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/genetics , Trisomy , Child , Child, Preschool , Chromosome Aberrations , Diploidy , Female , Follow-Up Studies , Humans , Infant , Male , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/diagnosis , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/mortality , Prognosis , Survival Analysis
2.
Eur Surg Res ; 42(1): 28-34, 2009.
Article in English | MEDLINE | ID: mdl-18987471

ABSTRACT

BACKGROUND: Nitric oxide (NO) plays a role in inflammation. Our aim was to investigate the role of NO in the microcirculatory changes after ischemia-reperfusion (I/R) of the bladder using intravital videomicroscopy (IVM). METHODS: In rats, 60 min of bladder ischemia followed by 30 min of reperfusion was performed in the presence of N(G)-nitro-L-arginine methyl ester (L-NAME), the NO precursor L-arginine, or saline pre-treatments. Venular red blood cell velocity (RBCV), functional capillary density (FCD), vessel diameters, and leukocyte-endothelial cell interactions in postcapillary venules were determined. Concentrations of nitrite/nitrate in the plasma and myeloperoxidase (MPO) levels in the lungs and the bladder were measured. RESULTS: Elevations of the numbers of rolling and adherent leukocytes, and of plasma nitrite/nitrate levels were found, while FCD and RBCV decreased. L-NAME pretreatment ameliorated the enhanced leukocyte-endothelial cell interactions without influencing the microcirculatory perfusion. In contrast, the L-arginine pretreatment further increased plasma nitrite/nitrate levels and preserved the FCD and RBCV, but did not affect leukocyte-endothelial interactions. None of these treatments influenced MPO activities. CONCLUSION: Our results suggest that NO plays an enhancing role in the I/R-induced neutrophil-endothelial interactions of the bladder. Supplementation of NO ameliorates the microcirculatory perfusion deficit without influencing the postischemic microcirculatory inflammatory reactions.


Subject(s)
Nitric Oxide/physiology , Reperfusion Injury/physiopathology , Urinary Bladder/blood supply , Urinary Bladder/injuries , Animals , Arginine/pharmacology , Blood Flow Velocity , Endothelial Cells/drug effects , Endothelial Cells/physiology , Enzyme Inhibitors/pharmacology , Erythrocytes/drug effects , Erythrocytes/physiology , Leukocyte Rolling/drug effects , Leukocyte Rolling/physiology , Male , Microcirculation/drug effects , Microcirculation/physiology , Microscopy, Video , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide Synthase/antagonists & inhibitors , Rats , Rats, Sprague-Dawley
5.
J Clin Pathol ; 56(5): 363-7, 2003 May.
Article in English | MEDLINE | ID: mdl-12719457

ABSTRACT

AIM: Gastrointestinal stromal tumours (GISTs) are uncommon mesenchymal neoplasms. Some metastasise, whereas others remain asymptomatic for years, but it is difficult to distinguish between them histologically. This report analyses the characteristics of seven metastasising GISTs and compares clinicopathological parameters of the metastatic and non-metastatic groups. METHODS/RESULTS: Histology revealed typical GIST features with spindle, epithelioid, or mixed appearance. All seven cases were positive for vimentin, five for neurone specific enolase, six for c-kit, four for S-100, three for PGP-9.5, three for CD-34 and synaptophysin, but all were negative for cytokeratin, neurofilament, chromogranin A, and desmin. Four showed a focal reaction for smooth muscle actin. Three of the tumours were GI, and two each were GII and GIII. The Ki-67 index varied from 4% to 44%, the three GI cases had 4%, 10%, and 16%. Tumours from the metastatic GIST group were significantly larger than those from the non-metastatic group. CONCLUSIONS: Three cases exhibited bland, GI histological features with moderate or low proliferative activity. Among the c-kit positive metastasising stromal tumours, some were low grade, with moderate or low mitotic and Ki-67 indices, emphasising the necessity to develop a reliable grading system for GIST to predict clinical behaviour, the importance of careful analysis of "benign looking" tumours, and the key role of c-kit status in identifying patients who could benefit from treatment with STI-571. Larger tumours had a higher chance of metastasising, and only the size of the primary tumour played a role in predicting metastatic potential.


Subject(s)
Gastrointestinal Neoplasms/pathology , Mesenchymoma/secondary , Adult , Aged , Biomarkers, Tumor/metabolism , Female , Gastrointestinal Neoplasms/metabolism , Humans , Leiomyosarcoma/metabolism , Leiomyosarcoma/pathology , Leiomyosarcoma/secondary , Liver Neoplasms/metabolism , Liver Neoplasms/pathology , Liver Neoplasms/secondary , Male , Mesenchymoma/metabolism , Mesenchymoma/pathology , Middle Aged , Mitotic Index , Neoplasm Proteins/metabolism , Proto-Oncogene Proteins c-kit/metabolism , Stromal Cells/pathology
6.
Histopathology ; 42(1): 53-60, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12493025

ABSTRACT

AIMS: The incidence, bone marrow morphology and genetic features of bcr+ essential thrombocythaemia were investigated. METHODS AND RESULTS: Sixty-four consecutive patients meeting the criteria of essential thrombocythaemia have been investigated for bcr-abl rearrangement and chimera mRNA expression. Reverse transcriptase-polymerase chain reaction indicated bcr-abl expression in six patients, in two of whom large fraction of the blood and bone marrow cells proved to be positive for Philadelphia chromosome (Ph) by fluorescent in-situ hybridization (FISH) and conventional cytogenetic analysis. In the remaining four patients FISH analysis could not detect Ph+ cells among the blood cells, but in one of these four patients conventional cytogenetic analysis indicated a very small fraction (2%) of Ph+ mitoses in the bone marrow (bcr+ essential thrombocythaemia patients). In three of these four patients, X-chromosome-linked clonality assay showed that the disease is of uncommitted stem cell origin. During an average of 57 month long follow-up no transformation to chronic myeloid leukaemia type of disease or acceleration/blastic crisis could be observed in the four bcr+ essential thrombocythaemia patients. They did not differ significantly from typical essential thrombocythaemia patients in quantitative indices of bone marrow cellularity or the size of megakaryocytes. In these two parameters as well as in the total nucleolus organizer region area per nucleus, however, significant differences could be detected between these four as well as typical chronic myeloid leukaemia patients. Statistical analysis of the morphometric data obtained from all six Ph+ and bcr+ essential thrombocythaemia patients combined indicated a shift of the bone marrow morphology towards the chronic myeloid leukaemia type of myeloproliferation. CONCLUSIONS: These investigations indicate that bcr+ essential thrombocythaemia is infrequent among essential thrombocythaemia patients, and this condition resembles essential thrombocythaemia more than chronic myeloid leukaemia. Various expansions of the Ph+ clone appear to lead to either essential thrombocythaemia or, rather, chronic myeloid leukaemia type of myeloproliferation; however, data in the present study do not indicate that bcr+ essential thrombocythaemia would be a form fruste variant of chronic myeloid leukaemia.


Subject(s)
Fusion Proteins, bcr-abl/genetics , Leukemia, Myeloid/genetics , Philadelphia Chromosome , RNA, Messenger/genetics , Thrombocytosis/genetics , Adult , Aged , Bone Marrow Cells/pathology , Cytogenetic Analysis , Female , Flow Cytometry , Humans , Image Processing, Computer-Assisted , Immunohistochemistry , Leukemia, Myeloid/etiology , Leukemia, Myeloid/pathology , Male , Megakaryocytes/pathology , Middle Aged , Polymerase Chain Reaction , Receptors, Androgen/metabolism , Thrombocytosis/complications , Thrombocytosis/pathology , Transcription, Genetic
7.
Clin Exp Rheumatol ; 21(6): 697-703, 2003.
Article in English | MEDLINE | ID: mdl-14740447

ABSTRACT

OBJECTIVE: Antibodies reacting with the m3 subtype muscarinic acetylcholine receptor appear to be an important pathogenic factor in primary Sjögren's syndrome (pSS). As this receptor subtype is functionally important in the gastrointestinal and urinary tracts, and very little is known about the autonomic nervous system function in these organs in pSS patients, the occurrence and clinical significance of an autonomic nervous system dysfunction involving the gastrointestinal and urinary tracts were investigated. METHODS: Data on clinical symptoms attributable to an autonomic dysfunction were collected from 51 pSS patients. Gastric emptying scintigraphy and urodynamic studies were performed on 30 and 16 patients, respectively, and the results were correlated with patient characteristics and with the presence of autonomic nervous system symptoms. RESULTS: Gastric emptying was abnormally slow in 21 of the 30 examined patients (70%). Urodynamic findings, compatible with a decreased detrusor muscle tone or contractility were found in 9 of the 16 patients tested (56%). Various symptoms of an autonomic nervous system dysfunction were reported by 2-16% of the patients. CONCLUSION: Signs of an autonomic nervous system dysfunction involving the gastrointestinal and the urinary systems can be observed in the majority of pSS patients. This high occurrence is rarely associated with clinically significant symptoms. The authors presume a role of autoantibodies reacting with the m3 muscarinic acetylcholine receptor in the elicitation of the autonomic dysfunction.


Subject(s)
Autonomic Nervous System Diseases/epidemiology , Gastrointestinal Diseases/epidemiology , Sjogren's Syndrome/epidemiology , Urologic Diseases/epidemiology , Adult , Age Distribution , Aged , Autonomic Nervous System Diseases/diagnosis , Comorbidity , Cross-Sectional Studies , Female , Gastric Emptying , Gastrointestinal Diseases/diagnosis , Humans , Incidence , Linear Models , Male , Middle Aged , Probability , Prognosis , Risk Assessment , Severity of Illness Index , Sex Distribution , Sjogren's Syndrome/diagnosis , Statistics, Nonparametric , Urodynamics , Urologic Diseases/diagnosis
9.
Bone Marrow Transplant ; 29(5): 449-52, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11919736

ABSTRACT

We report the case of a male patient with Ph-positive CML who developed AML 5 years after allogeneic BMT. Clinically, the AML seemed to develop on the basis of a myelodysplasia. The myeloid origin of blasts has been proven by immunophenotyping. The variable number of tandem repeats (VNTRs) and short tandem repeat (STR) showed donor-type haemopoiesis. The interphase FISH showed the XX genotype directly in the morphologically identifiable blasts and in the CD34-positive sorted bone marrow cells. This proved the new leukaemia to be of donor origin. The necessity of using multiple techniques and the advantage of combined immunophenotyping and FISH methods in this case is emphasized.


Subject(s)
Bone Marrow Transplantation/adverse effects , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/therapy , Leukemia, Myeloid/etiology , Neoplasms, Second Primary/etiology , Acute Disease , Cytogenetic Analysis , Female , Humans , Immunophenotyping , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/pathology , Leukemia, Myeloid/diagnosis , Leukemia, Myeloid/pathology , Male , Middle Aged , Neoplasms, Second Primary/diagnosis , Neoplasms, Second Primary/pathology , Tissue Donors , Transplantation Chimera , Transplantation, Homologous
10.
Acta Haematol ; 106(3): 100-5, 2001.
Article in English | MEDLINE | ID: mdl-11713374

ABSTRACT

Seven patients with Philadelphia (Ph) chromosome-positive chronic myeloid leukemia (CML) were treated with an ICE-based regimen plus G-CSF with the aim of mobilizing and collecting Ph-negative peripheral stem cells in the setting of an autologous transplant program. Five patients had CML in the first chronic phase and 2 in the accelerated phase. All patients had been previously treated with interferon-alpha. Median value and ranges for harvested mononuclear cells, CD34+ cells and CFU-GM, respectively: 5.65 x 10(8)/kg (2.61-11.38); 1.48 x 10(6)/kg (0.216-3.5), and 3.43 x 10(4)/kg (0.243-11.6). FISH was the only useful method for detection of minimal residual disease on apheresis product showing <5% t(9;22) positive cells in 2 cases and <10% positive cells in 4 other cases. Four of seven autologous grafts have been transplanted to date. Busulfan conditioning was used in 1 case and TBI/Cy conditioning in 3 other cases. All patients are alive and well following transplantation and are on interferon-alpha therapy.


Subject(s)
Hematopoietic Stem Cell Transplantation , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/therapy , Leukemia, Myeloid, Accelerated Phase/therapy , Leukemia, Myeloid, Chronic-Phase/therapy , Adult , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Biomarkers, Tumor/analysis , Bone Marrow Purging , Caspase 14 , Caspases/administration & dosage , Cell Survival , Colony-Forming Units Assay , Combined Modality Therapy , Cytarabine/administration & dosage , Etoposide/administration & dosage , Female , Filgrastim , Fusion Proteins, bcr-abl/analysis , Granulocyte Colony-Stimulating Factor/pharmacology , Hematopoietic Stem Cell Mobilization , Humans , Idarubicin/administration & dosage , Immunologic Factors/therapeutic use , Interferon-alpha/therapeutic use , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/pathology , Leukemia, Myeloid, Accelerated Phase/drug therapy , Leukemia, Myeloid, Accelerated Phase/pathology , Leukemia, Myeloid, Chronic-Phase/drug therapy , Leukemia, Myeloid, Chronic-Phase/pathology , Male , Recombinant Proteins , Remission Induction , Salvage Therapy , Transplantation Conditioning , Transplantation, Autologous , Treatment Outcome
12.
Magy Seb ; 54(4): 253-5, 2001 Aug.
Article in Hungarian | MEDLINE | ID: mdl-11550496

ABSTRACT

Hemangiopericytoma is a very rare tumour originating from the lining cells of small vessels. Despite benign histology it is clinical presentation similar to malignancy. There are only less than hundred cases reported sporadically in the literature. Authors report a case and successful radical removal of an infraperitoneal hemangiopericytoma infiltrating the left ureter. The literature of this strange, rare pathology is also analysed in the article.


Subject(s)
Hemangiopericytoma/secondary , Hemangiopericytoma/surgery , Peritoneal Neoplasms/surgery , Ureteral Neoplasms/secondary , Ureteral Neoplasms/surgery , Adult , Humans , Male , Peritoneal Neoplasms/pathology , Treatment Outcome
13.
Orv Hetil ; 142(20): 1049-54, 2001 May 20.
Article in Hungarian | MEDLINE | ID: mdl-11407066

ABSTRACT

Authors summarise the two-decade experience of their department in severe tissue necrosis of penis and scrotum. Presented cases represent a shared field of urology with dermatology, infectology, nephrology and andrology. Tissue necrosis extended to different depth of the penis, from superficial skin and subcutaneous tissues, fascias to the entire organ. Underlying diseases are acute and chronic inflammations, metabolic diseases, vascular lesions. Diagnostic difficulties and therapeutic choices, both conservative and operative, are discussed.


Subject(s)
Genital Diseases, Male/diagnosis , Genital Diseases, Male/etiology , Penis/pathology , Scrotum/pathology , Abscess/complications , Acute Disease , Adult , Chronic Disease , Fournier Gangrene/diagnosis , Genital Diseases, Male/pathology , Genital Diseases, Male/therapy , Humans , Inflammation/complications , Inflammation/diagnosis , Ischemia/complications , Ischemia/diagnosis , Male , Middle Aged , Necrosis , Penis/blood supply , Phimosis/complications , Priapism/complications , Scrotum/blood supply
14.
Nat Med ; 7(4): 471-7, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11283675

ABSTRACT

During ischemic stroke, neurons at risk are exposed to pathologically high levels of intracellular calcium (Ca++), initiating a fatal biochemical cascade. To protect these neurons, we have developed openers of large-conductance, Ca++-activated (maxi-K or BK) potassium channels, thereby augmenting an endogenous mechanism for regulating Ca++ entry and membrane potential. The novel fluoro-oxindoles BMS-204352 and racemic compound 1 are potent, effective and uniquely Ca++-sensitive openers of maxi-K channels. In rat models of permanent large-vessel stroke, BMS-204352 provided significant levels of cortical neuroprotection when administered two hours after the onset of occlusion, but had no effects on blood pressure or cerebral blood flow. This novel approach may restrict Ca++ entry in neurons at risk while having minimal side effects.


Subject(s)
Indoles/pharmacology , Potassium Channels, Calcium-Activated , Potassium Channels/drug effects , Stroke/drug therapy , Animals , Brain/metabolism , CHO Cells , Calcium/metabolism , Cell Line , Cricetinae , Disease Models, Animal , Dogs , Glutamic Acid/metabolism , Humans , In Vitro Techniques , Indoles/pharmacokinetics , Indoles/toxicity , Large-Conductance Calcium-Activated Potassium Channels , Male , Patch-Clamp Techniques , Potassium Channels/metabolism , Rats , Rats, Sprague-Dawley , Rats, Wistar , Safety , Stroke/metabolism , Synaptic Transmission/drug effects
15.
Virchows Arch ; 438(2): 173-80, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11253120

ABSTRACT

Four alveolar soft-part sarcomas were investigated by means of standard immunohistochemistry and interphase cytogenetics to further characterize the immunophenotype and proliferative activity of this tumor. The main goal of this study was to explore the chromosomal changes of this rare soft-tissue sarcoma. One epithelial (KLI), three neurogenic [neuron specific enolase (NSE), PGP 9.5, and S100], and five myogenic (desmin, myoglobin, alpha-smooth mnuscle actin, alpha-sarcomeric actin, and MyoD1) markers were used for the immunophenotypical analysis. Proliferative activity was assessed using the Ki67 index. Twelve (peri)centromeric (1, 3, 4, 6, 7, 8, 10, 12, 15, 17, 18, and X) and one telomeric (17q25-qtel.) chromosomal probes were used for interphase cytogenetic analysis. Three of the cases showed cytoplasmic desmin and/or myoglobin, and one showed smooth muscle actin positivity. All of the four tumors had granular, cytoplasmic, possibly nonspecific MyoD1 and sarcomeric actin positivity. Two of the tumors were positive for vimentin, four gave focal and weak staining with neurogenic markers (four of four NSE, one of four S100, and four of four PGP 9.5), but none of them was positive with KLI. Alveolar soft-part sarcomas may show myogenic immunophenotype in a number of cases, which supports myogenic differentiation. Fluorescent in situ hybridization using alpha satellite chromosomal probes revealed significant alterations in all of the cases. Most frequent and repeated numerical changes, which seem to be characteristic of the neoplasm and may play an important part in its pathogenesis and/or progression, were trisomy 7, monosomy 8 and monosomy 18.


Subject(s)
Chromosomes, Human, Pair 18 , Chromosomes, Human, Pair 7 , Chromosomes, Human, Pair 8 , Sarcoma, Alveolar Soft Part/genetics , Soft Tissue Neoplasms/genetics , Trisomy , Adolescent , Adult , Biomarkers, Tumor/analysis , Female , Humans , In Situ Hybridization, Fluorescence , Interphase , Male , Middle Aged , Neoplasm Proteins/analysis , Sarcoma, Alveolar Soft Part/chemistry , Sarcoma, Alveolar Soft Part/pathology , Soft Tissue Neoplasms/chemistry , Soft Tissue Neoplasms/pathology
16.
J Clin Pathol ; 54(3): 241-5, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11253140

ABSTRACT

AIM: Solid and papillary epithelial neoplasm (SPEN) is an uncommon pancreatic tumour. Very rarely it has also been described outside the pancreas, usually arising from heterotopic pancreatic tissue. This report summarises all the published extrapancreatic SPENs and documents the sixth such case arising from heterotopic pancreatic tissue of the transverse mesocolon in a 15 year old girl. METHODS/RESULTS: Histological and immunohistochemical examination revealed typical papillary and solid areas composed of columnar, cuboidal, and round cells, which were focally positive for vimentin, cytokeratin, neurone specific enolase, carcinoembryonic antigen, alpha1-antitrypsin, alpha1-antichymotrypsin, and negative for neuroendocrine markers (neurofilament, PGP 9.5, chromogranin A, synaptophysin, and S100), p53, and oestrogen and progesterone receptors. Electron microscopy showed scant zymogen but no neurosecretory granules. In agreement with the flow cytometric result s of diploidy, comparative genomic hybridisation (CGH) did not reveal loss or gain of genetic material, and the in situ hybridisation analysis of the RB1 and p53 genes revealed no abnormality in the 13q and 17p arms. CONCLUSIONS: Immunohistochemical and electron microscopic data support exocrine differentiation. The CGH and the flow cytometric results suggest a subtle, yet unknown genetic change, rather than a large genetic alteration. RB1 and p53 in situ hybridisation ruled out the role of deletion at these sites in the pathogenesis of SPEN. Interestingly, review of the published and the present heterotopic pancreatic SPENs identified the mesocolon as the most common anatomical site (four of six), despite the very rare occurrence of ectopic pancreatic tissue at this site.


Subject(s)
Carcinoma, Papillary/etiology , Choristoma/complications , Mesocolon , Neoplasms, Glandular and Epithelial/etiology , Pancreas , Peritoneal Neoplasms/etiology , Adolescent , Female , Humans , Peritoneal Diseases/complications
17.
J Urol ; 165(4): 1279-82, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11257701

ABSTRACT

PURPOSE: Chronic over distention may lead to enterocystoplasty rupture. It is hypothesized that pressure induced microvascular derangement and subsequent ischemia of the enterocystoplasty intestinal patch may have a role in this process. We describe distention induced microcirculatory alterations in a chronic rat model of enterocystoplasty using intravital video microscopy. MATERIALS AND METHODS: Microcirculation in the muscle layer of the intact bladder and intestine, and in the enterocystoplasty 90 days after surgery were examined at greater and less than urethral sphincter closure pressure. Microcirculatory changes were recorded during stepwise increments of intraluminal pressure up to 80 mm. Hg or when 20 mm. Hg was continuously maintained for 60 minutes. RESULTS: The enterocystoplasty components of intestine and bladder displayed baseline microcirculatory characteristics similar to those observed in the intact organs. As evidenced by microcirculatory flow and functional capillary density measurements in the intact intestine and the ileal portion of enterocystoplasty, intraluminal pressure elevation to greater than 25 or 30 mm. Hg significantly compromised capillary perfusion by approximately 50% and 75%, respectively. Lower intraluminal pressure did not cause microcirculatory disturbance even when maintained for a longer period. In the intact bladder and bladder portion of enterocystoplasty only pressure increases to greater than 80 mm. Hg affected tissue perfusion. CONCLUSIONS: Intravital microscopy in the augmented rat bladder is a sensitive and suitable means of assessing clinically relevant microcirculatory changes. These experiments demonstrate the significance of distention induced microcirculatory impairment in the intact bowel and the intestinal site of enterocystoplasty even at less than urethral closure pressure.


Subject(s)
Muscle, Smooth/blood supply , Urinary Bladder/surgery , Urinary Diversion , Animals , Disease Models, Animal , Male , Microcirculation , Rats , Rats, Wistar , Urinary Bladder/blood supply
18.
Magy Onkol ; 45(1): 9-13, 2001.
Article in Hungarian | MEDLINE | ID: mdl-12050722

ABSTRACT

For most chronic myeloid leukaemia patients the option of a potentially curative allogeneic stem cell transplantation is not available because of age or lack of donor. Alternative therapy with interferon-alpha appears to prolong survival but is probably not curative. The aim of the study is to analyse the clinical results of the first Hungarian autologous transplantations in CML. METHODS: Seven patients were treated with ICE-based regimen plus G-CSF with the aim of mobilising and collecting Ph-negative peripheral stem cells in the setting of autologous transplant program. Five patients had CML in first chronic phase and two in accelerated phase. All patients have been previously treated with interferon-alpha. RESULTS: Median value and ranges for harvested mononuclear cells, CD34(+) cells and CFU-GM were: 5.65x10(8)/kg (2.61-11.38), 1.48x10(6)/kg (0.216-3.5) and 3.43x10(4)/kg (0.243-11.6), respectively. Four out of seven autologous grafts have been transplanted. Busulfan conditioning was used in one case and TBI/Cy conditioning in three patients. All patients are alive and well post-transplant being on interferon-alpha therapy. CONCLUSIONS: Based on the clinical advantages of autologous transplantation including long-term chronic phase, achievement of second chronic phase and improved response to interferon-alpha therapy, the procedure can offer an alternative treatment in CML in lack of HLA-identical donor.

19.
J Eur Acad Dermatol Venereol ; 15(5): 476-80, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11763397

ABSTRACT

Necrotizing histiocytic lymphadenopathy (NHL) is a rarely observed clinical entity that is occasionally associated with systemic lupus erythematosus (SLE). The histological features of the condition have been considered to be indistinguishable from those of lymphadenitis in subjects with SLE, and the clinical symptoms of the two disorders share common features. This report presents the case history of a subject who developed SLE with central nervous system involvement 3 years following onset of Kikuchi's disease (histiocytic necrotizing lymphadenitis). Repeated lymph node biopsies confirmed the diagnosis in relation to the clinical progression. A review of the literature on this topic is also presented.


Subject(s)
Histiocytic Necrotizing Lymphadenitis/pathology , Lupus Erythematosus, Systemic/pathology , Adrenal Cortex Hormones/administration & dosage , Adult , Aspirin/administration & dosage , Biopsy, Needle , Cyclophosphamide/administration & dosage , Diagnosis, Differential , Drug Therapy, Combination , Female , Follow-Up Studies , Histiocytic Necrotizing Lymphadenitis/diagnosis , Histiocytic Necrotizing Lymphadenitis/drug therapy , Humans , Immunohistochemistry , Lupus Erythematosus, Systemic/diagnosis , Lupus Erythematosus, Systemic/drug therapy , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...